HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Pituitary and Adrenal Gland Disorders

Hormonal imbalances originating from the pituitary and adrenal gland disorders significantly affect metabolic regulation, stress response, and glucose homeostasis. Conditions such as Cushing’s syndrome, Addison’s disease, and acromegaly disrupt normal endocrine signaling, contributing to insulin resistance, hypertension, and cardiovascular complications. Advances in endocrinology have led to targeted therapies, including hormone replacement and receptor-specific drugs, to restore balance. Imaging technologies and molecular diagnostics have improved early detection, allowing for timely interventions. Understanding the connections between pituitary-adrenal dysfunction and metabolic diseases enables the development of more precise treatment strategies. Ongoing research continues to refine therapeutic options, offering new hope for patients with complex endocrine disorders.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp